🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 9 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/03/2017 13,69 13,90 13,25 13,67 -0,94% 4,73% 23.000
03/03/2017 14,41 14,42 13,66 13,80 -2,61% 5,27% 35.800
02/03/2017 14,74 14,86 14,02 14,17 -3,80% 5,73% 28.000
01/03/2017 14,00 14,95 13,84 14,73 +6,28% 7,93% 81.000
28/02/2017 14,29 14,50 13,51 13,86 -3,88% 6,93% 43.200
27/02/2017 14,45 14,74 14,05 14,42 +0,14% 4,78% 23.700
24/02/2017 13,85 15,03 13,77 14,40 +3,15% 9,10% 82.500
23/02/2017 14,78 14,96 13,64 13,96 -4,25% 8,93% 17.700
22/02/2017 15,39 15,39 14,38 14,58 -3,89% 6,56% 52.900
21/02/2017 14,92 15,29 14,24 15,17 +0,00% 7,04% 43.900
17/02/2017 15,18 15,88 14,83 15,17 +0,53% 6,92% 83.700
16/02/2017 14,92 15,29 14,38 15,09 -0,20% 6,10% 24.400
15/02/2017 14,69 15,22 14,26 15,12 +2,23% 6,54% 38.800
14/02/2017 15,46 15,72 14,58 14,79 -5,13% 7,37% 22.200
13/02/2017 15,60 16,06 15,10 15,59 -0,19% 6,15% 17.200
10/02/2017 15,90 16,19 15,39 15,62 -1,70% 5,03% 11.900
09/02/2017 16,51 17,10 15,65 15,89 -6,09% 8,76% 33.400
08/02/2017 17,98 18,20 16,60 16,92 -5,47% 8,90% 25.300
07/02/2017 18,37 19,01 17,57 17,90 -5,64% 7,84% 35.300
06/02/2017 19,06 19,73 18,28 18,97 -0,89% 7,61% 8.900
03/02/2017 18,89 19,26 17,70 19,14 +2,68% 8,23% 18.300
02/02/2017 18,50 19,84 18,44 18,64 +2,36% 7,57% 15.500
01/02/2017 18,63 19,15 18,04 18,21 +0,94% 5,96% 4.600
31/01/2017 18,73 18,75 17,64 18,04 -4,04% 5,93% 14.500
30/01/2017 19,29 19,89 18,40 18,80 -2,49% 7,72% 16.200
27/01/2017 19,95 19,96 19,25 19,28 -3,46% 3,56% 16.100
26/01/2017 19,45 20,14 18,71 19,97 +2,31% 7,38% 21.100
25/01/2017 18,47 19,60 17,76 19,52 +5,74% 9,97% 23.700
24/01/2017 17,77 18,78 17,42 18,46 +3,88% 7,65% 21.600
23/01/2017 17,73 18,14 17,19 17,77 +0,23% 5,33% 32.900